SELLAS Life Sciences Group Inc.
SLS | NASDAQ
$11.79
+$0.42 (+3.69%)
Sep 22, 2026, 1:44 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1M | n/a | n/a | 1.9M | 5.7M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 100K | n/a | n/a | 100K | 100K |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 900K | n/a | n/a | 1.8M | 5.6M |
Operating Income | -10.63M | -9.25M | -8.26M | -7.08M | -6.87M | -6.06M | -6.92M | -7.33M | -7.62M | -9.65M | -8.18M | -9.36M | -9.05M | -11.28M | -9.45M | -7.15M | -8.62M | -6.74M | -5.92M | -6.98M | -4.45M | -2.25M |
Interest Income | 1.02M | 845K | 597K | 292K | 272K | 250K | 181K | 221K | 151K | 79K | 41K | 94K | 208K | 182K | 158K | 111K | 46K | 2K | n/a | 2K | 2K | 2K |
Pretax Income | -9.61M | -8.41M | -7.66M | -6.79M | -6.6M | -5.81M | -6.74M | -7.11M | -7.47M | -9.57M | -8.14M | -9.27M | -8.84M | -11.1M | -9.12M | -7.02M | -8.41M | -16.74M | -6.84M | -7.09M | -4.61M | -2.4M |
Net Income | -9.61M | -8.41M | -7.66M | -6.79M | -6.6M | -5.81M | -6.74M | -7.11M | -7.47M | -9.57M | -8.14M | -9.27M | -8.84M | -11.1M | -9.12M | -7.02M | -8.41M | -16.74M | -6.6M | -7.09M | -4.61M | -2.4M |
Selling & General & Admin | 4.36M | 4.12M | 3.53M | 2.87M | 3M | 2.86M | 2.48M | 2.97M | 2.44M | 4.53M | 3.08M | 3.55M | 3.13M | 4.11M | 3.6M | 2.86M | 3.09M | 3.02M | 2.53M | 2.44M | 2.8M | 3.56M |
Research & Development | 6.27M | 5.13M | 4.73M | 4.22M | 3.87M | 3.21M | 4.44M | 4.36M | 5.19M | 5.11M | 5.1M | 5.81M | 5.92M | 7.17M | 5.85M | 4.28M | 5.53M | 4.61M | 3.39M | 4.54M | 3.46M | 4.28M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 10.63M | 9.25M | 8.26M | 7.08M | 6.87M | 6.06M | 6.92M | 7.33M | 7.62M | 9.65M | 8.18M | 9.36M | 9.05M | 11.28M | 9.45M | 7.15M | 8.62M | 7.64M | 5.92M | 6.98M | 6.25M | 7.85M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10.63M | 9.25M | 8.26M | 7.08M | 6.87M | 6.06M | 6.92M | 7.33M | 7.62M | 9.65M | 8.18M | 9.36M | 9.05M | 11.28M | 9.45M | 7.15M | 8.62M | 7.74M | 5.92M | 6.98M | 6.35M | 7.95M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -237K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 189.18M | 172.48M | 153.1M | 108.4M | 94.3M | 87.76M | 73.99M | 68.25M | 57.46M | 44.81M | 30.8M | 28.36M | 28.35M | 23.55M | 20.79M | 20.56M | 20.29M | 15.9M | 15.89M | 15.87M | 15.27M | 14.88M |
Shares Outstanding (Diluted) | 189.18M | 172.48M | 153.1M | 108.4M | 98.56M | 87.76M | 73.99M | 68.25M | 57.63M | 44.81M | 30.8M | 28.36M | 28.35M | 23.55M | 20.79M | 20.56M | 20.29M | 15.9M | 15.89M | 15.87M | 15.27M | 14.88M |
EPS (Basic) | -0.05 | -0.05 | -0.05 | -0.06 | -0.07 | -0.07 | -0.09 | -0.10 | -0.13 | -0.21 | -0.26 | -0.33 | -0.31 | -0.47 | -0.44 | -0.34 | -0.41 | -1.05 | -0.42 | -0.45 | -0.30 | -0.16 |
EPS (Diluted) | -0.05 | -0.05 | -0.05 | -0.06 | -0.07 | -0.07 | -0.09 | -0.10 | -0.13 | -0.21 | -0.26 | -0.33 | -0.31 | -0.47 | -0.44 | -0.34 | -0.41 | -1.05 | -0.42 | -0.45 | -0.30 | -0.16 |
EBITDA | -9.61M | -8.41M | -7.66M | 292K | -6.6M | -5.81M | -6.74M | -7.11M | -7.47M | -9.57M | -8.14M | -9.27M | -8.68M | -11.1M | -9M | -6.82M | -8.33M | -16.7M | -5.56M | -7.09M | -4.61M | -1.4M |
EBIT | -9.61M | -8.41M | -7.66M | -6.79M | -6.6M | -5.81M | -6.74M | -7.11M | -7.47M | -9.57M | -8.14M | -9.27M | -8.84M | -11.1M | -9.12M | -7.02M | -8.41M | -16.74M | -6.84M | -7.09M | -4.61M | -2.25M |
Depreciation & Amortization | n/a | n/a | n/a | 7.08M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 158K | n/a | 123K | 207K | 82K | 45K | 1.27M | n/a | n/a | 846K |
Add to Watchlist
Select watchlists to add or remove SLS